Masimo Corporation
NASDAQ:MASIMedical - Devices
+$0.00 today
- Market cap
- $9.42B
- Beta
- 1.10
- P/E (TTM)
- 123.1
- EPS (TTM)
- $1.46
Volume 0.00M
Average 1.08M
MASI Common Stock Issued
Cash raised by issuing new shares.
Masimo CorporationNASDAQ: MASI
Common Stock Issued · Q1 FY2026 · quarter ended Apr 2026
Common stock issued declines year over year
Q1 FY2026 common stock issued of $10M fell 76.8% year over year, behind the -37.4% change in trailing-twelve-month common stock issued. Sequentially, it fell 15.3% from the prior quarter. Over 3 fiscal years it compounded at +106.6% a year.
Context
- Common stock issued amounted to 4.7% of revenue in FY2025, up 3.5 pp from a year earlier.
- Common stock issued increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -76.8% toward the trailing-twelve-month pace of -37.4%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 71.4M USD
- Year-over-year change
- +183.3%
- 4-year CAGR
- +32.5%
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 71.4M | +183.3% |
| FY2024 | 2024-12-28 | 25.2M | +260.0% |
| FY2023 | 2023-12-31 | 7M | -13.6% |
| FY2022 | 2022-12-31 | 8.1M | -65.1% |
| FY2021 | 2021-12-31 | 23.2M | — |
Common Stock Issued vs competitors
How MASI compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock issued is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -37.4% is the 5th highest of 8, against a peer median of +0.0%.
- Common stock issued amounts to 2.5% of revenue for MASI, versus a peer median of 0.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | €588.84M EUR | +135576.3% | +133.3% | — | |
| LTM Jun 2026 | $86.6M USD | +1961.9% | — | 3.3% | |
| LTM Apr 2026 | $38.3M USD | -37.4% | +106.6% | 2.5% | |
| LTM Jun 2026 | $35M USD | +0.0% | -38.2% | 0.3% | |
| LTM Jun 2026 | $23M USD | — | — | 0.6% | |
| LTM Jun 2026 | $14.36M USD | -461.8% | -5.0% | 1.8% | |
| LTM Sep 2026 | $4.61M USD | -98.2% | +22.0% | 1.6% | |
| LTM Jun 2026 | $4.4M USD | — | — | 0.1% | |
| LTM Jun 2026 | $3M USD | -98.8% | — | 0.0% | |
| LTM Sep 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2026 | €0 EUR | +100.0% | — | 0.0% | |
| Peer median (excluding MASI) | — | +0.0% | +8.5% | 0.3% | |
Competitors are the stored peer set for MASI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | 229.6M | 143.5M | 81.5M | (304.9M) | (151.5M) |
| Depreciation & Amortization | 35.6M | 136.1M | 98.3M | 103M | 38.8M |
| Deferred Income Tax | (15.1M) | (39.3M) | (35.6M) | (38.2M) | 11.8M |
| Stock-Based Compensation | 44.7M | 47.7M | 7M | 41.5M | 35.8M |
| Change in Working Capital | (31.5M) | (261.8M) | (70.9M) | (10.7M) | (89.9M) |
| Accounts Receivables | (76.9M) | (151.3M) | 91.9M | (60.2M) | 17.2M |
| Inventory | 13.5M | (155.9M) | (69.2M) | (7.5M) | (112.1M) |
| Accounts Payables | 11M | 60.5M | (19.6M) | 14.8M | (27.1M) |
| Other Working Capital | 20.9M | (15.1M) | (74M) | 42.2M | 32.1M |
| Other Non-Cash Items | 1.3M | 3.2M | 13.8M | 405.7M | 372.2M |
| Operating Cash Flow | 264.6M | 29.4M | 94.1M | 196.4M | 217.2M |
| Capital Expenditures | (34.9M) | (56.3M) | (87.7M) | (51.1M) | (19.4M) |
| Acquisitions (Net) | 0 | (999.7M) | 7.5M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | (12M) | (5.2M) | (44.7M) | (31.2M) | 294.5M |
| Investing Cash Flow | (37.5M) | (1.06B) | (81.2M) | (51.2M) | 275.1M |
| Debt Repayment | 0 | 939.2M | (51.2M) | (146.8M) | (207.8M) |
| Common Stock Issued | 23.2M | 8.1M | 7M | 25.2M | 71.4M |
| Common Stock Repurchased | (128.9M) | (401.5M) | 0 | 0 | (363.7M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (16.7M) | (25.4M) | (12.9M) | (4M) | (20.6M) |
| Financing Cash Flow | (122.4M) | 520.4M | (57.1M) | (125.6M) | (520.7M) |
| Effect of Forex Changes | (1.3M) | (30.9M) | 2.8M | (6.4M) | 53.8M |
| Net Change in Cash | 103.4M | (538.8M) | (41.4M) | 13.2M | 26M |
| Free Cash Flow | 229.7M | (26.9M) | 6.4M | 145.3M | 197.8M |
Masimo Corporation
NASDAQ:MASI
Intrinsic Alpha fair value
Locked
Current Price
$179.95
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.